Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-13 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-11 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-10 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-09 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.32 | 2e-08 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |